Company intelligence / Profile preview

Cambridge Healthcare Innovations

Cambridge, Cambridgeshire, United Kingdom

Ownership: Private
Employees: ~9
Development stage: Other

Overview

Cambridge Healthcare Innovations (CHI) has developed and patented novel dry powder inhaler (DPI) platforms such as αeolus and qtechnology, aiming to significantly improve the delivery of respiratory medicines by enabling high payload delivery to the deep lung with reliable performance. Clinical results have not been published, indicating pre-clinical or pre-market status.

Therapeutic areas: Pulmonology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Kindeva Drug Delivery

Beyond the preview

Go deeper on Cambridge Healthcare Innovations.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cambridge Healthcare Innovations.

Explore the full profile